DRUG NEWS
May 24, 2020
4 minutes
Heartburn drug Zantac linked to stomach cancers
The heartburn drug Zantac may have been taken off the shelves late last year, but the repercussions go on. More than a dozen lawsuits have been filed that claim the drug causes cancer, especially of the digestive tract.
One complainant, Californian Ronald Johnson, has been taking 150 mg of the drug regularly since 2004. He was diagnosed with cancer in 2018. He joins more than 12 other complainants to file damages against the drug manufacturers Boehringer Ingelheim, Sanofi, Pfizer and GlaxoSmithKline, who have all made versions of Zantac (ranitidine), including over-the-counter
You’re reading a preview, subscribe to read more.
Start your free 30 days